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Helicobacter pylori secretes a pore-forming toxin, VacA, that can cause numerous alterations in gastric
epithelial cells and T lymphocytes. In this issue of Cell Host & Microbe, Sewald and colleagues report that
b2 integrin (CD18) mediates entry of VacA into human T cells. Downregulation of T cell responses by VacA
may allow H. pylori to evade the adaptive immune response and establish persistent infection.Helicobacter pylori is a Gram-negative
bacterium that persistently colonizes the
human stomach. Chronic colonization
with H. pylori is a risk factor for the devel-
opment of gastric adenocarcinoma, gas-
tric lymphoma, and peptic ulcer disease.
H. pylori produces several proteins that
can modulate the physiology of cells within
the gastric mucosa. One such protein,
VacA, is a pore-forming toxin that is se-
creted into the extracellular space via
a type V (autotransporter) pathway (Cover
and Blanke, 2005). VacA was originally
identified based on its capacity to cause
the formation of large intracellular vacu-
oles, corresponding to swollen late endo-
somal compartments. Subsequent stud-
ies showed that VacA can cause
numerous other cellular alterations, includ-
ing activation of mitogen-activated protein
(MAP) kinases, increased plasma mem-
brane permeability, increased mitochon-
drial membrane permeability, reduced
barrier function of polarized epithelial
monolayers, and apoptosis.
Several putative receptors for VacA on
the surface of gastric epithelial cells have
been identified, including receptor-like
protein tyrosine phosphatases (RPTPa
and b) and glycosphingolipids. Following
binding of VacA to the surface of cells,
the toxin can insert into the plasma mem-
brane to form anion-selective membrane
channels. In addition, VacA can be inter-
nalized by cells via a clathrin-independent
pinocytotic pathway, and then localizes
to endosomal compartments or mito-
chondria. Glycosylphosphatidylinositol-
anchored proteins and lipid rafts have
been implicated in the processes leadingto VacA channel formation and VacA
internalization. Most VacA-induced cellu-
lar alterations are dependent on insertion
of the toxin into cellular membranes to
form membrane channels.
Recent investigations have shown that
VacA can intoxicate not only gastric epi-
thelial cells, but also various types of
immune cells. Effects of VacA on T lym-
phocytes have been studied in the most
detail. Studies of a cultured T cell line
(Jurkat cells) indicate that VacA blocks
activation of the transcription factor nu-
clear factor of activated T cells (NFAT),
which results in inhibition of IL-2 gene
transcription and numerous other tran-
scriptional changes (Boncristiano et al.,
2003; Gebert et al., 2003; Sundrud et al.,
2004). This effect of VacA resembles the
actions of immunosuppressive drugs such
as cyclosporine and FK506, which inacti-
vate the NFAT phosphatase calcineurin.
VacA inhibits the activation-induced prolif-
eration of primary human CD4+ T cells, but
in contrast to what is observed with Jurkat
cells, VacA has relatively little if any inhibi-
tory effect on IL-2 expression if the cells
are activated with CD3/CD28 antibodies
(Oswald-Richter et al., 2006; Sundrud et al.,
2004; Torres et al., 2007). VacA inhibits
IL-2-induced proliferation of activated
primary human CD4+ T cells due to a G1
cell cycle arrest, without affecting IL-2-
dependent survival. The inhibitory effect
of VacA on IL-2-driven cell cycle progres-
sion resembles the action of the immuno-
suppressive drug rapamycin, but in con-
trast to rapamycin, VacA does not have
any detectable effect on p70 S6 kinase
(Oswald-Richter et al., 2006; SundrudCell Host & Micet al., 2004; Torres et al., 2007). VacA-
treated primary human CD4+ T cells ex-
hibit alterations in mitochondrial function,
which may account for the observed in-
hibition of proliferation. Interestingly, pri-
mary murine CD4+ T cells are resistant
to the actions of VacA (Algood et al.,
2007). Thus, there are differences in the
effects of VacA on cultured T cell lines,
primary human T cells, and primary murine
T cells, but the basis for these differences
has not been elucidated. It has been
suggested that downregulation of T cell
responses by VacA may contribute to H.
pylori persistence.
A study in this issue of Cell Host &
Microbe provides important new insights
into the molecular mechanisms by which
VacA intoxicates T cells (Sewald et al.,
2008). Sewald and colleagues began by
examining the interactions of VacA with
primary human CD4+ T cells and found
that activation of the cells with phorbol
myristate acetate (PMA) enhanced the
susceptibility of these cells to VacA.
VacA inhibited IL-2 production by PMA-
activated cells, whereas VacA had rela-
tively little effect on resting (nonactivated)
T cells. VacA bound to the trailing edge
(uropod) of PMA-activated migrating
CD4+ T cells and was internalized by
PMA-activated cells, whereas VacA bound
nonfocally to resting cells and was not in-
ternalized by resting cells. Based on these
observations, the authors reasoned that
cellular factors affected by PMA treat-
ment might mediate VacA interactions
with T cells. Specifically, the authors
hypothesized that integrins might be
involved.robe 3, January 2008 ª2008 Elsevier Inc. 5
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PreviewsIntegrins are heterodimeric transmem-
brane receptors, comprised of a and
b subunits, that mediate an assortment
of cellular adhesive interactions and
transmit signals across the plasma mem-
brane. Numerous bacteria, viruses, and
bacterial toxins are known to enter eukary-
otic cells via processes that require integ-
rins. T cells can express about 12 different
types of integrin heterodimers, including
several leukocyte-specific b2 integrins
(Hogg et al., 2003). Leukocyte function-
associated antigen-1 (LFA-1; CD11a/
CD18), the most abundant of the T cell
b2 integrins, has an important role in T
cell adherence to vascular endothelium
and in formation of the immunologic
synapse between T cells and antigen-
presenting cells. LFA-1 is typically in an
inactive state in circulating T cells, but it
becomes rapidly activated when T cells
encounter various stimuli.
In the study by Sewald et al. (2008), mul-
tiple lines of experimental evidence pro-
vided support for the hypothesis that b2
integrin (CD18) has an important role in
VacA interactions with T cells. Specifi-
cally, microscopic imaging of activated
primary human CD4+ T cells showed that
VacA colocalized with CD18 or CD11a at
the uropod of cells, and after incubation
with cells for 1 hr, VacA colocalized with
LFA-1 in small intracellular vesicles. Treat-
ment of activated primary human CD4+
T cells with calpeptin (an inhibitor of cal-
pain, a Ca2+-dependent protease required
for the release of integrins from the cytos-
keleton and integrin clustering) blocked
internalization of VacA into the cells.
Immunoprecipitation experiments demon-6 Cell Host & Microbe 3, January 2008 ª2008strated that VacA interacted with CD18 in
both cultured T cell lines and primary hu-
man CD4+ T cells. LFA-1-deficient Jurkat
T cells were resistant to VacA-induced
vacuolation and inhibition of IL-2 tran-
scription, and genetic complementation
of the defect restored VacA sensitivity.
Moreover, expression of human b2 integ-
rin heterodimers in Chinese hamster ovary
(CHO) cells, which lack human integrins,
enhanced the susceptibility of these cells
to VacA-induced vacuolation.
Sewald et al. (2008) also analyzed the
interactions of VacA with murine T cells.
In contrast to primary human CD4+ T cells,
primary murine spleen CD4+ T cells and
cells from a murine T lymphoblast cell
line (EL4) were resistant to the actions of
VacA, and VacA was not internalized by
PMA-activated murine CD4+ cells. Ex-
pression of human LFA-1 in murine EL4
T cells increased the susceptibility of
these cells to VacA actions. The specific
targeting of human CD18 (but not murine
CD18) by VacA is consistent with a long
coevolution of H. pylori and humans
(Blaser and Kirschner, 2007). Since mu-
rine T cells are resistant to VacA, it may
be presumed that current mouse models
of H. pylori infection provide an incom-
plete view of VacA actions in vivo.
In summary, the current study by Sew-
ald et al. (2008) offers important new
insights into the process by which VacA
intoxicates T cells. Further studies will be
needed to understand more completely
how VacA alters T cell function. For exam-
ple, Sewald et al. (2008) suggest that
CD18 may not be the only cell surface re-
ceptor for VacA on T cells, and therefore,Elsevier Inc.it will be important to identify other cell
surface components that may have
a role in VacA binding to T cells. In addi-
tion, it will be important to investigate the
intracellular trafficking of VacA and iden-
tify putative intracellular targets of VacA
in human T cells.
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